|
Market Closed -
Nasdaq
06:00:00 02/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 1.985 USD | -0.75% |
|
-8.53% | +44.89% |
| 14/08 | Allogene Therapeutics Remains Attractive Given Valuation, Clinical Strategy, RBC Says | MT |
| 13/08 | Allogene Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.75% | -8.53% | +5.59% | -7.67% | +44.89% | +75.66% | -50.99% | -91.99% | - | 691M | |
| -0.25% | -4.10% | +20.22% | +54.42% | +70.34% | +38.38% | +92.61% | +16.28% | - | 68.13B | |
| +1.21% | +0.80% | +18.95% | +23.43% | +23.63% | +46.29% | +85.32% | +211.28% | +6,252.69% | 63.6B | |
| +1.31% | -5.21% | +27.72% | +42.92% | +57.38% | +37.52% | +12.07% | -57.64% | - | 25.57B | |
| -0.25% | -1.92% | +23.24% | +14.60% | -30.18% | -10.72% | +436.70% | +317.13% | +807.47% | 26.6B | |
| +0.33% | -10.61% | +12.55% | +11.17% | +7.09% | +1.95% | -16.27% | -69.34% | - | 25.52B | |
| -6.09% | -12.08% | +23.58% | +51.06% | +209.18% | +226.11% | +375.00% | +1,801.66% | +854.21% | 18.23B | |
| +1.18% | -2.23% | +15.52% | +30.99% | +5.92% | +30.87% | -19.04% | -28.60% | +102.74% | 19.69B | |
| -1.49% | -6.44% | +1.24% | +12.49% | +24.89% | +0.78% | +540.26% | - | - | 15.16B | |
| +4.12% | +0.30% | +7.28% | +13.15% | +29.80% | +52.03% | +150.18% | +191.15% | +401.23% | 13.54B | |
| -0.24% | +5.18% | +15.28% | +11.94% | -7.49% | +23.04% | +190.97% | +543.93% | +4,434.60% | 12.48B | |
| +0.42% | -6.91% | -2.26% | +10.03% | +24.63% | +275.58% | +195.92% | +20.81% | +1,071.95% | 11.64B | |
| -4.73% | -3.66% | -8.83% | -26.10% | -24.20% | -45.79% | +148.62% | +116.84% | - | 10.56B | |
| +3.96% | +5.99% | +8.76% | -9.87% | -19.04% | -40.25% | +768.71% | +94.51% | +112.96% | 10.87B | |
| +0.69% | -7.82% | -7.43% | -3.09% | +12.37% | +102.09% | +98.33% | +116.23% | +580.00% | 9.86B | |
| +0.13% | +0.11% | +1.71% | +146.09% | +82.49% | +174.12% | +387.10% | +254.25% | - | 9.01B | |
| +0.12% | -0.46% | +12.44% | +24.33% | +31.79% | +97.50% | +14.52% | +125.89% | - | 9.04B | |
| -1.01% | -3.91% | +9.76% | +8.70% | +297.47% | +236.32% | +414.38% | -33.31% | - | 8.43B | |
| -1.67% | -1.18% | -2.94% | +1.21% | +10.21% | -21.67% | +116.80% | -22.59% | - | 8.55B | |
| -0.93% | -17.57% | -10.00% | +25.46% | +170.15% | +436.69% | +510.34% | -51.17% | -38.81% | 7.88B | |
| Average | -0.15% | -2.24% | +8.62% | +21.76% | +51.07% | +86.82% | +222.58% | +181.86% | +1,457.90% | 18.75B | |
| Weighted average by Cap. | +0.06% | -2.11% | +14.10% | +28.12% | +44.53% | +61.48% | +180.20% | +187.66% | +2,657.84% |
- Stock Market
- Stocks
- ALLO Stock
- Sector Allogene Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
